Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
NCT03551600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2023-04-04
Summary
Patent ductus arteriosus (PDA) is a common problem in the neonatal intensive care unit and can be secondary to prematurity or congenital heart disease (CHD). PDA is the most common cardiovascular abnormality in preterm infants, and is seen in 55% of infants born at 28 weeks, and 1000 grams or less. In addition to producing heart failure and prolonged respiratory distress or ventilator dependence, PDA has been implicated in development of broncho-pulmonary dysplasia, interventricular hemorrhage, cerebral ischemia, and necrotizing enterocolitis (NEC). In an Israeli population study 5.6% of all very low birth weight infants (VLBW) were diagnosed with NEC, and 9.4% of VLBW infants with PDA were found to have NEC. In a retrospective analysis of neonates with CHD exposed to Prostaglandin E found that the odds of developing NEC increased in infants with single ventricle physiology, especially hypoplastic left heart syndrome. The proposed pathophysiological explanation of NEC and PDA is a result of "diastolic steal" where blood flows in reverse from the mesenteric arteries back into the aorta leading to compromised diastolic blood flow and intestinal hypo-perfusion. Prior studies have demonstrated that infants with a hemodynamically significant PDA have decreased diastolic flow velocity of the mesenteric and renal arteries when measured by Doppler ultrasound, and an attenuated intestinal blood flow response to feedings in the post prandial period compared to infants without PDA. Near Infrared Spectroscopy (NIRS) has also been used to assess regional oxygen saturations (rSO2) in tissues such as the brain, kidney and mesentery in premature infants with PDA. These studies demonstrated lower baseline oxygenation of these tissues in infants with hemodynamically significant PDA. These prior NIRS studies evaluated babies with a median gestational age at the time of study of 10 days or less. It is unknown if this alteration in saturations will persist in extubated neonates with PDA at 12 or more days of life on full enteral feedings.
In the present study the investigators hypothesize that infants with a PDA, whether secondary to prematurity or ductal dependent CHD, will have decreased splanchnic and renal perfusion and rSO2 renal/splanchnic measurements will be decreased during times of increased metabolic demand such as enteral gavage feeding. To test this hypothesis the investigators have designed a prospective observational study utilizing NIRS to record regional saturations at baseline, during feedings, and after feedings for 48 hours.
Conditions
- Infant, Premature
- Congenital Heart Disease
- Patent Ductus Arteriosus
- Necrotizing Enterocolitis
Interventions
- PROCEDURE
-
Near-infrared spectroscopy (NIRS)
NIRS analyzes regional oxygen saturations (rSO2)
Sponsors & Collaborators
-
Intermountain Health Care, Inc.
collaborator OTHER - lead OTHER
Principal Investigators
-
Mariana Baserga, MD · University of Utah
Eligibility
- Min Age
- 12 Days
- Max Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2022-02-09
- Completion
- 2022-06-30
Countries
- United States
Study Locations
More Related Trials
-
Patent Ductus Arteriosus and Splanchnic Oxygenation at First Feed
NCT03723889 ·Status: COMPLETED
-
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants
NCT05547165 ·Status: RECRUITING ·Phase: NA
-
NIRS in PDA VLBW Infants
NCT02396004 ·Status: COMPLETED
-
PDA Post NICU Discharge
NCT02750228 ·Status: COMPLETED
-
Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
NCT00162903 ·Status: COMPLETED
-
Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
NCT00795990 ·Status: COMPLETED
-
Conditions of Realization of the Echocardiography in Newborns
NCT02893956 ·Status: COMPLETED ·Phase: NA
-
The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
NCT00500305 ·Status: COMPLETED ·Phase: NA
-
Description of Changes in NIRS as a Function of Ductus Arteriosus Status in Very Premature Babies Born Before 32 WG at the DIJON University Hospital
NCT06153771 ·Status: COMPLETED
-
Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies
NCT00725647 ·Status: COMPLETED
-
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
NCT01790750 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.
NCT04379843 ·Status: COMPLETED
-
Changes in Renal and Splanchnic Oxygenation During Ibuprofen Treatment for Patent Ductus Arterious
NCT01251939 ·Status: COMPLETED
-
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
NCT06373289 ·Status: RECRUITING ·Phase: NA
-
Happy Baby Hearts Study
NCT05842876 ·Status: COMPLETED
-
Right vEntricular Function Prediction mOdel to Identify pReterm infanTs With Early BronchoPulmonary Dysplasia.
NCT05235399 ·Status: COMPLETED
-
Management of the PDA Trial
NCT03456336 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Auscultation and Pulse Oximetry Combined Screening of Neonatal Congenital Heart Disease
NCT05105880 ·Status: COMPLETED
-
Study of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants
NCT06627374 ·Status: RECRUITING
-
Noninvasive Hemodynamics Assessment of Preterms With Successful Medical Closure of PDA
NCT06606015 ·Status: COMPLETED
-
Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis
NCT01735578 ·Status: COMPLETED
-
Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
NCT00554307 ·Status: WITHDRAWN
-
PDA Stent in Neonates With PDA Dependent Pulmonary Circulation
NCT05857293 ·Status: UNKNOWN ·Phase: NA
-
Splanchnic Oxygenation Response to Enteral Feeds in Preterm Infants With Abnormal Antenatal Doppler.
NCT02971566 ·Status: COMPLETED
-
Detection of Neonatal Bradycardia
NCT00950287 ·Status: COMPLETED